Skip to Content

Blirt SA - Stock Quote BLR

Rating as of

Morningstar's Blirt SA Stock Analysis

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - BLR

Blirt SA's Company Profile

Business Description

Blirt SA is a research and development company conducting research and providing contract services in the scope of biotechnology, microbiology, chemical synthesis and analytics. The company specializes in proteins, analytics, chemical syntheses and DNA Gdansk.

Trzy Lipy 3/1.38
Gdansk, 80-172, Poland
T +48 587396150
Industry Biotechnology
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2019
Stock Type
Employees 75